Pharma companies

Genelux is a clinical-stage biopharmaceutical company developing an oncolytic virus-based technology platform.

Dyne Therapeutics is a biotechnology company which is engaged in the development of targeted therapies for patients with serious muscle diseases.

Sol-Gel Technologies is engaged in the development of a range of specialty pharmaceuticals.

Nuvalent is a preclinical-stage biopharmaceutical company focused on creating targeted therapies for patients with cancer.

Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases.

Gracell Biotechnologies is a clinical-stage biotech company developing cell gene therapies for cancer.

Avicanna is a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products.

Aravive is a clinical-stage biotechnology company developing therapies for solid tumors and hematologic malignancies.

Omega Therapeutics is an epigenomic medicine company.

Nektar Therapeutics is a stage-clinical biopharmaceutical company.

INmune Bio is a clinical-stage biotechnology company that develops immunotherapies that reprogram a patient’s innate immune system.

Dynavax Technologies Corporation is a biopharmaceutical company discovering and developing novel products to prevent and treat infectious, autoimmune and inflammatory diseases, and the treatment of cancer.